Yestar Healthcare Holdings Company Limited (HKG:2393)
0.1100
-0.0040 (-3.51%)
Jan 21, 2026, 1:52 PM HKT
HKG:2393 Revenue
Yestar Healthcare Holdings Company had revenue of 802.63M CNY in the half year ending June 30, 2025, a decrease of -45.50%. This brings the company's revenue in the last twelve months to 1.94B, down -28.56% year-over-year. In the year 2024, Yestar Healthcare Holdings Company had annual revenue of 2.41B, down -17.26%.
Revenue (ttm)
1.94B CNY
Revenue Growth
-28.56%
P/S Ratio
0.12
Revenue / Employee
3.09M CNY
Employees
627
Market Cap
256.47M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.41B | -502.82M | -17.26% |
| Dec 31, 2023 | 2.91B | 108.21M | 3.86% |
| Dec 31, 2022 | 2.80B | -2.13B | -43.12% |
| Dec 31, 2021 | 4.93B | 823.75M | 20.06% |
| Dec 31, 2020 | 4.11B | -796.33M | -16.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |